These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1403 related items for PubMed ID: 29679301

  • 1. Contemporary Antithrombotic Treatment in Patients with Non-valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: Rationale and Design of the Greek AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
    Xanthopoulou I, Dragona VM, Davlouros P, Tsioufis C, Iliodromitis E, Alexopoulos D, GRAPE-AF Investigators.
    Cardiovasc Drugs Ther; 2018 Apr; 32(2):191-196. PubMed ID: 29679301
    [Abstract] [Full Text] [Related]

  • 2. Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective-2018 Update.
    Angiolillo DJ, Goodman SG, Bhatt DL, Eikelboom JW, Price MJ, Moliterno DJ, Cannon CP, Tanguay JF, Granger CB, Mauri L, Holmes DR, Gibson CM, Faxon DP.
    Circulation; 2018 Jul 31; 138(5):527-536. PubMed ID: 30571525
    [Abstract] [Full Text] [Related]

  • 3. Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials?
    Duerschmied D, Brachmann J, Darius H, Frey N, Katus HA, Rottbauer W, Schäfer A, Thiele H, Bode C, Zeymer U.
    Clin Res Cardiol; 2018 Jul 31; 107(7):533-538. PubMed ID: 29679144
    [Abstract] [Full Text] [Related]

  • 4. Risk of Stroke vs. Intracerebral Hemorrhage in Patients with Non-Valvular Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Comparing Dual vs. Triple Antithrombotic Therapy.
    Desai A, Escamilla-Ocanas C, Dilip D, Saber H, Damani R.
    J Stroke Cerebrovasc Dis; 2021 Apr 31; 30(4):105654. PubMed ID: 33578352
    [Abstract] [Full Text] [Related]

  • 5. Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis.
    Haller PM, Sulzgruber P, Kaufmann C, Geelhoed B, Tamargo J, Wassmann S, Schnabel RB, Westermann D, Huber K, Niessner A, Gremmel T.
    Eur Heart J Cardiovasc Pharmacother; 2019 Oct 01; 5(4):226-236. PubMed ID: 31198930
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Triple therapy: A review of antithrombotic treatment for patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Saito Y, Kobayashi Y.
    J Cardiol; 2019 Jan 01; 73(1):1-6. PubMed ID: 30293674
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Time-trends and treatment gaps in the antithrombotic management of patients with atrial fibrillation after percutaneous coronary intervention: Insights from the CHUM AF-STENT Registry.
    Boivin-Proulx LA, Deneault-Marchand A, Matteau A, Mansour S, Gobeil F, Camm JA, Fox KAA, Potter BJ.
    Clin Cardiol; 2020 Mar 01; 43(3):216-221. PubMed ID: 31850592
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Trends of Antithrombotic Treatment in Atrial Fibrillation Patients Undergoing Percutaneous Coronary Intervention: Insights from the GReek-AntiPlatElet Atrial Fibrillation (GRAPE-AF) Registry.
    Benetou DR, Varlamos C, Ktenas D, Tsiafoutis I, Koutouzis M, Bampali T, Mantis C, Zarifis J, Skalidis E, Aravantinos D, Varvarousis D, Lianos I, Kanakakis J, Pisimisis E, Ziakas A, Davlouros P, Alexopoulos D, GRAPE-AF investigators.
    Cardiovasc Drugs Ther; 2021 Feb 01; 35(1):11-20. PubMed ID: 33034806
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents.
    Choi HI, Ahn JM, Kang SH, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park DW, Park SJ.
    JACC Cardiovasc Interv; 2017 Jun 12; 10(11):1075-1085. PubMed ID: 28527773
    [Abstract] [Full Text] [Related]

  • 20. Atrial fibrillation, bleeding, and coronary intervention: current recommendations.
    Farhan S, Mehran R.
    Coron Artery Dis; 2017 Dec 12; 28(8):702-709. PubMed ID: 28938240
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 71.